Not finding it? Sign in to also search OpenAlex live.
-
Clinical and Demographic Factors Associated With Kaposi Sarcoma–Associated Herpesvirus Shedding in Saliva or Cervical Secretions in a Cohort of Tanzanian Women2024 Open Forum Infectious Diseases article Medicine Viral-associated cancers and disorders Open access
Anna M. Mertelsmann, Crispin Mukerebe, Donald Miyaye, Peter Shigella, Loyce Mhango, Peter Lutonja, +12 more
4citations -
First-in-human administration of a live-attenuated RSV vaccine lacking the G-protein assessing safety, tolerability, shedding and immunogenicity: a randomized controlled trial
Pauline Verdijk, Johan L. van der Plas, Emilie M.J. van Brummelen, Rienk E. Jeeninga, Cornelis A. M. de Haan, Meta Roestenberg, +2 more
31citations -
Prolonged fecal shedding of replication-competent virus, lasting immune activation, and intestinal inflammation in a rhesus macaque after experimental SARS-CoV-2 infection2024 Frontiers in Cellular and Infection Microbiology article Medicine SARS-CoV-2 and COVID-19 Research Open access
Kinga P. Böszörményi, Marieke A. Stammes, Zahra C. Fagrouch, Henk Niphuis, Gwendoline Kiemenyi Kayere, Lisette Meijer, +8 more
2citations -
Modelling the effectiveness of an isolation strategy for managing mpox outbreaks with variable infectiousness profiles2024 Nature Communications article Immunology and Microbiology Poxvirus research and outbreaks Open access
Yong Dam Jeong, William S. Hart, Robin N. Thompson, Masahiro Ishikane, Takara Nishiyama, Hyeongki Park, +10 more
14citations -
Successful treatment of prolonged COVID-19 with Bamlanivimab in a patient with severe B-Cell aplasia due to treatment with an anti-CD20 monoclonal antibody: A case report2021 Respiratory Medicine Case Reports article Medicine COVID-19 Clinical Research Studies Open access
Ayham Daher, Tobias Müller, Jens Spießhoefer, Michael Dreher, Jens Panse
8citations -
Replication, safety and immunogenicity of the vectored Ebola vaccine rVSV-ΔG-ZEBOV-GP in a sub-Saharan African paediatric population: A randomised controlled, open-label trial in children aged 1-12 years living in Lambaréné, Gabon
Ayodele Kamal ALABI, Kossiwa Kokou, Saïdou Mahmoudou, Ranmali Kavishna, Sravya Sowdamini Nakka, Sylvia Rothenberger, +12 more
8citations -
Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial2020 The Lancet Infectious Diseases article Medicine Viral Infections and Outbreaks Research Open access cited by 7 patents
Andrew John Pollard, Odile Launay, Jean‐Daniel Lelièvre, Christine Lacabaratz, Sophie Grande, Neil H. Goldstein, +84 more
173citations -
Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group
Anne Mea Spanjaart, Per T Ljungman, Rafael de la Cámara, Gloria Tridello, Valentín Ortiz‐Maldonado, Álvaro Urbano-Ispizúa, +28 more
115citations
19 results